Stock Research for MNKD

MNKD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

MNKD Stock Chart & Research Data

The MNKD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MNKD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MNKD Due diligence Resources & Stock Charts

The MNKD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MNKD Detailed Price Forecast - CNN Money CNN View MNKD Detailed Summary - Google Finance
Yahoo View MNKD Detailed Summary - Yahoo! Finance Zacks View MNKD Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View MNKD Trends & Analysis - Trade-Ideas Barrons View MNKD Major Holders - Barrons
NASDAQ View MNKD Call Transcripts - NASDAQ Seeking View MNKD Breaking News & Analysis - Seeking Alpha
Spotlight View MNKD Annual Report - CompanySpotlight.com OTC Report View MNKD OTC Short Report - OTCShortReport.com
TradeKing View MNKD Fundamentals - TradeKing Charts View MNKD SEC Filings - Bar Chart
WSJ View Historical Prices for MNKD - The WSJ Morningstar View Performance/Total Return for MNKD - Morningstar
MarketWatch View the Analyst Estimates for MNKD - MarketWatch CNBC View the Earnings History for MNKD - CNBC
StockMarketWatch View the MNKD Earnings - StockMarketWatch MacroAxis View MNKD Buy or Sell Recommendations - MacroAxis
Bullish View the MNKD Bullish Patterns - American Bulls Short Pains View MNKD Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View MNKD Stock Mentions - StockTwits PennyStocks View MNKD Stock Mentions - PennyStockTweets
Twitter View MNKD Stock Mentions - Twitter Invest Hub View MNKD Investment Forum News - Investor Hub
Yahoo View MNKD Stock Mentions - Yahoo! Message Board Seeking Alpha View MNKD Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for MNKD - SECform4.com Insider Cow View Insider Transactions for MNKD - Insider Cow
CNBC View MNKD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MNKD - OTC Markets
Yahoo View Insider Transactions for MNKD - Yahoo! Finance NASDAQ View Institutional Holdings for MNKD - NASDAQ


Stock Charts

FinViz View MNKD Stock Insight & Charts - FinViz.com StockCharts View MNKD Investment Charts - StockCharts.com
BarChart View MNKD Stock Overview & Charts - BarChart Trading View View MNKD User Generated Charts - Trading View




Latest Financial News for MNKD


MannKind Announces CFO Transition
Posted on Tuesday March 26, 2024

Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through December 31, 2024Christopher Prentiss appointed Chief Financial Officer, effective April 22, 2024 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lu


Jim Cramer Says You Should Avoid These 11 Stocks
Posted on Monday March 25, 2024

In this article, we will take a detailed look at Jim Cramer Says You Should Avoid These 11 Stocks. For a quick overview of such stocks, read our article Jim Cramer Says You Should Avoid These 5 Stocks. Jim Cramer in his latest program took a jab at the Department of Justice and Washington authorities in general, calling regulators […]


INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
Posted on Monday March 11, 2024

Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered through MDI or insulin pumpsSubjects utilizing inhaled insulin experienced a 22% decrease in mean glucose excursions in the first two hours compared to the standard of care17-week primary endpoint results will be presented during a 90-minute symposium at the American Diabetes Association’s Scientific Sessions in June DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 11, 202


MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
Posted on Tuesday March 05, 2024

Dr. Hirsch to present meal challenge results when switching from multiple daily injections (MDI) or insulin pumps to inhaled insulin (Afrezza® (insulin human) Inhalation Powder)DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that new clinical data from the I


Stock Market & Investing Books

Enter a stock symbol to view the stock details.